The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs raises aveanna healthcare target to four fifty maintains sell rating
UBS has raised its price target for Aveanna Healthcare Holdings Inc to $4.50 from $3.20 while maintaining a Sell rating. Despite trading at $5.31 and a recent 33.5% gain, the company reported a negative EPS of -$0.34 over the last year, though it exceeded revenue expectations in Q4 2024 with $519.9 million. Aveanna's full-year revenue reached $2.024 billion, reflecting a 6.8% increase, driven by a 10.1% growth in its Private Duty Services segment.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.